UBS Group
GH icon

UBS Group’s Guardant Health GH Stock Holding History

UBS Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,200
Closed -$1.57M – 10528
2025
Q2 		$1.57M Buy
+30,200
New +$1.35M ﹤0.01% 5049
2024
Q2 		– Sell
-40,000
Closed -$825K – 9719
2024
Q1 		$825K Buy
+40,000
New +$857K ﹤0.01% 4754

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's GH Position: Q1 2026 in Review

UBS Group reduced its Guardant Health (GH) stake by 18% in Q1 2026, selling an estimated $30.6M and leaving 1,405,837 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #856.

UBS Group first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $175M in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • UBS Group held 1,405,837 shares of Guardant Health worth $130M as of Q1 2026.
  • UBS Group sold 304,332 Guardant Health shares in Q1 2026, an estimated $30.6M.
  • Guardant Health made up 0.02% of UBS Group's portfolio in Q1 2026, its #856 holding.
  • UBS Group first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • UBS Group's Guardant Health position peaked at $175M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.